Loading...
XSHE002382
Market cap647mUSD
Jan 10, Last price  
4.74CNY
1D
-2.67%
1Q
-7.42%
Jan 2017
-61.05%
IPO
-49.93%
Name

Blue Sail Medical Co Ltd

Chart & Performance

D1W1MN
XSHE:002382 chart
P/E
—
P/S
0.96
EPS
—
Div Yield, %
10.82%
Shrs. gr., 5y
6.21%
Rev. gr., 5y
13.18%
Revenues
4.93b
+0.54%
358,787,182405,019,994516,652,774477,702,866621,540,628933,651,6221,333,379,9501,335,188,0191,535,087,4481,508,984,6861,288,770,7191,575,945,3092,653,120,0793,475,614,1547,869,425,1448,108,586,4644,900,477,5694,927,074,862
Net income
-568m
33,842,88030,865,19161,357,95459,849,72440,334,40129,061,79751,197,41446,974,23661,701,864170,211,819181,069,380200,864,341346,714,031490,295,0861,758,477,2551,155,709,1910-568,360,487
CFO
-73m
L
12,009,32616,077,85175,913,94262,047,36500153,821,697133,891,561150,958,834261,299,378163,926,593227,567,253649,366,180782,789,0963,671,535,9962,245,545,736494,468,136-72,885,826
Dividend
May 31, 20230.4 CNY/sh
Earnings
May 20, 2025

Profile

Blue Sail Medical Co.,Ltd. manufactures and sells health protection gloves in China and internationally. The company offers disposable medical, latex, nitrile, PVC, TPE, and household gloves that are used for medical inspection and protection, food processing, electronics industry, etc. It is also involved in the research, development, production, and sales of cardiac stents and interventional cardiac surgery related equipment products. The company was formerly known as Shandong Blue Sail Plastic & Rubber Co., Ltd. and changed its name to Blue Sail Medical Co.,Ltd. in July 2014. Blue Sail Medical Co.,Ltd. was founded in 2002 and is based in Zibo, China.
URL
http://www.bluesail.cn/
IPO date
Apr 02, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
4,927,075
0.54%
4,900,478
-39.56%
Cost of revenue
5,014,993
5,233,639
Unusual Expense (Income)
NOPBT
(87,918)
(333,161)
NOPBT Margin
Operating Taxes
(54,250)
Tax Rate
NOPAT
(33,668)
(333,161)
Net income
(568,360)
 
Dividends
(513,776)
Dividend yield
7.71%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
543,079
368,707
Long-term debt
1,840,245
2,860,742
Deferred revenue
70,354
Other long-term liabilities
278,024
19,483
Net debt
(1,308)
507,029
Cash flow
Cash from operating activities
(72,886)
494,468
CAPEX
(774,144)
Cash from investing activities
(870,747)
114,819
Cash from financing activities
133,306
FCF
21,587
133,306
Balance
Cash
1,590,108
2,525,420
Long term investments
794,525
197,001
Excess cash
2,138,279
2,477,397
Stockholders' equity
3,851,934
4,855,697
Invested Capital
10,056,963
11,342,982
ROIC
ROCE
EV
Common stock shares outstanding
997,124
1,007,095
Price
6.68
-14.25%
7.79
-52.18%
Market cap
6,660,786
-15.10%
7,845,270
-54.16%
EV
6,659,478
8,352,299
EBITDA
436,595
155,846
EV/EBITDA
15.25
53.59
Interest
180,467
129,477
Interest/NOPBT